130 related articles for article (PubMed ID: 10785891)
21. [Long-term treatment of central diabetes insipidus with oral DDAVP].
Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a new antidiuretic agent, desmopressin acetate (DDAVP).
Kosman ME
JAMA; 1978 Oct; 240(17):1896-7. PubMed ID: 691204
[TBL] [Abstract][Full Text] [Related]
23. [Pseudoresistance to DDAVP in diabetes insipidus].
Radó J; Pató E; Czigner J; Fáber K
Orv Hetil; 1985 Aug; 126(33):2043-6. PubMed ID: 4034192
[No Abstract] [Full Text] [Related]
24. [Diabetes insipidus in infancy and childhood].
Sólyom J; Bognár I; Mátyus J
Orv Hetil; 1981 May; 122(19):1125-8. PubMed ID: 7267106
[No Abstract] [Full Text] [Related]
25. DDAVP (1-desamino-8-D-arginine-vasopressin) treatment of central diabetes insipidus--mechanism of prolonged antidiuresis.
Seif SM; Zenser TV; Ciarochi FF; Davis BB; Robinson AG
J Clin Endocrinol Metab; 1978 Mar; 46(3):381-8. PubMed ID: 221517
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
[TBL] [Abstract][Full Text] [Related]
27. Management of cranial diabetes insipidus with oral desmopressin (DDAVP).
Cunnah D; Ross G; Besser GM
Clin Endocrinol (Oxf); 1986 Mar; 24(3):253-7. PubMed ID: 3708875
[TBL] [Abstract][Full Text] [Related]
28. [The treatment of diabetes insipidus in 1999].
Ajzenberg C; Warnet A
Rev Med Interne; 1999 Aug; 20 Suppl 3():399s-400s. PubMed ID: 10480192
[No Abstract] [Full Text] [Related]
29. Comparison of the antidiuretic effects of single intravenous and intranasal doses of DDAVP in diabetes insipidus.
Radó JP; Marosi J; Fischer J
Pharmacology; 1977; 15(1):40-5. PubMed ID: 840889
[TBL] [Abstract][Full Text] [Related]
30. [Persistent central diabetes insipidus in a very low birth weight infant].
Quetin F; Garnier H; Brauner R; Vodovar M; Magny JF
Arch Pediatr; 2007 Nov; 14(11):1321-3. PubMed ID: 17916426
[TBL] [Abstract][Full Text] [Related]
31. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
[TBL] [Abstract][Full Text] [Related]
32. Vasopressin analog DDAVP in the treatment of diabetes insipidus.
Lee WP; Lippe BM; La Franchi SH; Kaplan SA
Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613
[TBL] [Abstract][Full Text] [Related]
33. Neurogenic diabetes insipidus: management with dDAVP (1-desamino-8-D arginine vasopressin).
Cobb WE; Spare S; Reichlin S
Ann Intern Med; 1978 Feb; 88(2):183-8. PubMed ID: 626447
[TBL] [Abstract][Full Text] [Related]
34. Improved psychological status of children under DDAVP therapy for central diabetes insipidus.
Waggoner RW; Slonim AE; Armstrong SH
Am J Psychiatry; 1978 Mar; 135(3):361-2. PubMed ID: 626231
[No Abstract] [Full Text] [Related]
35. Effects of lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients.
Laczi F; Valkusz Z; Lászlo FA; Wagner A; Járdánházy T; Szász A; Szilárd J; Telegdy G
Psychoneuroendocrinology; 1982; 7(2-3):185-93. PubMed ID: 7178372
[TBL] [Abstract][Full Text] [Related]
36. Management of diabetes insipidus with DDAVP.
Lampert RP; Blackett PR; Rennert OM
J Pediatr; 1978 Nov; 93(5):896-7. PubMed ID: 712511
[No Abstract] [Full Text] [Related]
37. [Experiences with intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP). Use in the diagnosis of hypophyseal function].
Tuschy U; Szeszat S; Meinhold J
Z Gesamte Inn Med; 1983 Sep; 38(17):475-7. PubMed ID: 6636917
[TBL] [Abstract][Full Text] [Related]
38. [Experiences with the intranasal and parenteral use of 1-desamino-8-D-arginine vasopressin (DDAVP)--effect of one time parenteral and intranasal applications].
Tuschy U; Meinhold J; Szeszat S
Z Gesamte Inn Med; 1983 Aug; 38(16):450-2. PubMed ID: 6636913
[TBL] [Abstract][Full Text] [Related]
39. Ten-year experience with DDAVP in treatment of diabetes insipidus.
Marek J; Loutocký A; Pacovský V; Zaoral M
Endokrinologie; 1978 May; 72(2):188-94. PubMed ID: 738214
[TBL] [Abstract][Full Text] [Related]
40. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
